-
EP4355777
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4355777
| EP4355777 - CELLS EXPRESSING VISTA ANTIGEN-BINDING MOLECULES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 22.03.2024 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 23.12.2022 | ||
| Former | unknown Status updated on 27.06.2022 | Most recent event Tooltip | 15.08.2024 | Change: Validation states | published on 18.09.2024 [2024/38] | 15.08.2024 | Change - extension states | published on 18.09.2024 [2024/38] | Applicant(s) | For all designated states Hummingbird Bioscience Pte. Ltd. No. 04-01/11 The Aries Singapore Science Park II Singapore 117586 / SG | [2024/17] | Inventor(s) | 01 /
BOYD-KIRKUP, Jerome Douglas Singapore 117586 / SG | 02 /
INGRAM, Piers Singapore 117586 / SG | 03 /
THAKKAR, Dipti Singapore 117586 / SG | 04 /
GUAN, Siyu Singapore 117586 / SG | 05 /
SADASIVAM, Akila Singapore 117586 / SG | [2024/17] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2024/17] | Application number, filing date | 22731262.6 | 13.06.2022 | [2024/17] | WO2022EP66061 | Priority number, date | GB20210008446 | 14.06.2021 Original published format: GB 202108446 | [2024/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022263388 | Date: | 22.12.2022 | Language: | EN | [2022/51] | Type: | A1 Application with search report | No.: | EP4355777 | Date: | 24.04.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.12.2022 takes the place of the publication of the European patent application. | [2024/17] | Search report(s) | International search report - published on: | EP | 22.12.2022 | Classification | IPC: | C07K16/28, C12N5/071 | [2024/17] | CPC: |
C12N5/0602 (EP);
C07K16/2827 (EP,US);
A61P35/00 (EP,US);
A61K2039/505 (US);
C07K2317/24 (US);
C07K2317/30 (EP);
C07K2317/33 (US);
C07K2317/73 (US);
C07K2317/92 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/17] | Title | German: | ZELLEN ZUR EXPRESSION VON VISTA-ANTIGENBINDENDEN MOLEKÜLEN | [2024/17] | English: | CELLS EXPRESSING VISTA ANTIGEN-BINDING MOLECULES | [2024/17] | French: | CELLULES EXPRIMANT DES MOLÉCULES DE LIAISON À L'ANTIGÈNE VISTA | [2024/17] | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 20.12.2023 | National basic fee paid | 20.12.2023 | Designation fee(s) paid | 20.12.2023 | Examination fee paid | Examination procedure | 20.12.2023 | Examination requested [2024/17] | 20.12.2023 | Date on which the examining division has become responsible | 05.07.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 19.06.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XDI]WO2019185879 (HUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD [SG], et al); | [XI]WO2019185163 (HUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD [SG], et al); | [I]TWI684601B (JANSSEN PHARMACEUTICA NV [BE]); | [XI]US10633456 (BOYD-KIRKUP JEROME DOUGLAS [SG], et al); | [I]WO2020186111 (XCELLA BIOSCIENCES INC [US], et al); | by applicant | US2012301919 | WO2017023749 | US9631018 | WO2019185879 |